Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406) - Kopetz, S; Guthrie, K A; Morris, V K (J Clin Oncol, 2020)
;(epub ahead of print)